Cymabay Therapeu Probability of Future Stock Price Finishing Under 6.27
| CBAYDelisted Stock | USD 11.83 0.27 2.34% |
Cymabay |
Cymabay Therapeu Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cymabay Therapeu for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cymabay Therapeu can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cymabay Therapeu is not yet fully synchronised with the market data | |
| Cymabay Therapeu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 31.07 M. Net Loss for the year was (105.37 M) with loss before overhead, payroll, taxes, and interest of (41.63 M). | |
| Cymabay Therapeu currently holds about 153.42 M in cash with (72.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 10230 shares by Mike Ouimette of Pliant Therapeutics at 10.9934 subject to Rule 16b-3 |
Cymabay Therapeu Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cymabay Stock often depends not only on the future outlook of the current and potential Cymabay Therapeu's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cymabay Therapeu's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.2 M | |
| Cash And Short Term Investments | 394.3 M |
Cymabay Therapeu Technical Analysis
Cymabay Therapeu's future price can be derived by breaking down and analyzing its technical indicators over time. Cymabay Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cymabay Therapeu. In general, you should focus on analyzing Cymabay Stock price patterns and their correlations with different microeconomic environments and drivers.
Cymabay Therapeu Predictive Forecast Models
Cymabay Therapeu's time-series forecasting models is one of many Cymabay Therapeu's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cymabay Therapeu's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cymabay Therapeu
Checking the ongoing alerts about Cymabay Therapeu for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cymabay Therapeu help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cymabay Therapeu is not yet fully synchronised with the market data | |
| Cymabay Therapeu has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 31.07 M. Net Loss for the year was (105.37 M) with loss before overhead, payroll, taxes, and interest of (41.63 M). | |
| Cymabay Therapeu currently holds about 153.42 M in cash with (72.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.81. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from MacroaxisInsider: Disposition of 10230 shares by Mike Ouimette of Pliant Therapeutics at 10.9934 subject to Rule 16b-3 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Cymabay Stock
If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |